Ioscovich, A., Shen, O., Sichel, J.Y., Lajos, Y., Orkin, D., Bromiker, R. and Briskin, A. (2011) Remifentanil-nitroglycerin combination as an anesthetic support for ex utero intrapartum treatment (EXIT) procedure. Journal of Clinical Anesthesia, 23, 142-144. http://dx.doi.org/10.1016/j.jclinane. 2009.12.014

has been cited by the following article:

• TITLE: Ex Utero intrapartum treatment (EXIT)

  AUTHORS: Srinivas Pentyala, Aleef Rahman, Pooja Mysore, Sahana Pentyala, Kyle Urbanczyk, Thomas Tumillo, John Muller, Yimei Miao, Sardar Khan

  KEYWORDS: Caesarean Section; Airway; Vaginal Birth; Anesthesia; Ex Utero Intrapartum Treatment; EXIT

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.3 No.9A, November 25, 2013

  ABSTRACT: The anesthesia ex utero intrapartum treatment (EXIT) procedure is a specialized surgical procedure used to deliver babies who have airway compression due to cystic adenomatoid malformation, bronchopulmonary sequestration, cervical teratomas, or other congenital conditions. EXIT is erroneously known as a routine cesarean section (CS), but is rather an extension of CS with discernible differences. The procedure creates an opening in the anesthetized abdomen of the mother and uterus. Once EXIT is complete, the remainder of the CS proceeds. EXIT is much more complex than a routine CS, as it requires coordination between the mother and a multidisciplinary team of surgical and neonatal personnel. This review highlights current anesthetic concepts during the EXIT procedure.